330 related articles for article (PubMed ID: 35473320)
1. [Interdisciplinary and Psychiatric Treatment of Anabolic Androgenic Steroids Users].
Butzke I; Iff S; Zitzmann M; Quednow BB; Claussen MC
Praxis (Bern 1994); 2022 Apr; 111(6):339-344. PubMed ID: 35473320
[TBL] [Abstract][Full Text] [Related]
2. Interdisciplinary and Psychiatric Treatment of Anabolic Androgenic Steroids Users.
Butzke I; Iff S; Zitzmann M; Quednow BB; Claussen MC
Praxis (Bern 1994); 2022 Apr; 111(6):e339-e344. PubMed ID: 35473322
[No Abstract] [Full Text] [Related]
3. [Recognizing IPED Use in Clinical Practice].
Iff S; Gähwiler R; Butzke I; Quednow BB; Claussen MC
Praxis (Bern 1994); 2022 Apr; 111(6):333-337. PubMed ID: 35473323
[TBL] [Abstract][Full Text] [Related]
4. Recognizing IPED Use in Clinical Practice.
Iff S; Gähwiler R; Butzke I; Quednow BB; Claussen MC
Praxis (Bern 1994); 2022 Apr; 111(6):e333-e337. PubMed ID: 35473328
[No Abstract] [Full Text] [Related]
5. The awareness and experience of healthcare providers with the use of anabolic androgenic steroids by gym users.
Izzat N; Abu-Farha R; Al-Mestarihi E; Alzoubi KH
Int J Legal Med; 2023 Nov; 137(6):1705-1711. PubMed ID: 37624373
[TBL] [Abstract][Full Text] [Related]
6. Effects of Anabolic Androgenic Steroids on the Reproductive System of Athletes and Recreational Users: A Systematic Review and Meta-Analysis.
Christou MA; Christou PA; Markozannes G; Tsatsoulis A; Mastorakos G; Tigas S
Sports Med; 2017 Sep; 47(9):1869-1883. PubMed ID: 28258581
[TBL] [Abstract][Full Text] [Related]
7. A qualitative assessment of anabolic-androgenic steroid use among gym users in Jordan: motives, perception, and safety.
Izzat N; Abu-Farha R; Harahsheh MM; Thiab S
Int J Legal Med; 2023 Sep; 137(5):1421-1430. PubMed ID: 37355480
[TBL] [Abstract][Full Text] [Related]
8. Impact of androgenic anabolic steroid use on cardiovascular and mental health in Danish recreational athletes: protocol for a nationwide cross-sectional cohort study as a part of the Fitness Doping in Denmark (FIDO-DK) study.
Buhl LF; Lehmann Christensen L; Diederichsen A; Lindholt JS; Kistorp CM; Glintborg D; Andersen M; Frystyk J
BMJ Open; 2024 May; 14(5):e078558. PubMed ID: 38719280
[TBL] [Abstract][Full Text] [Related]
9. Common symptoms associated with usage and cessation of anabolic androgenic steroids in men.
Sharma A; Grant B; Islam H; Kapoor A; Pradeep A; Jayasena CN
Best Pract Res Clin Endocrinol Metab; 2022 Sep; 36(5):101691. PubMed ID: 35999138
[TBL] [Abstract][Full Text] [Related]
10. Adverse health effects of anabolic-androgenic steroids.
van Amsterdam J; Opperhuizen A; Hartgens F
Regul Toxicol Pharmacol; 2010 Jun; 57(1):117-23. PubMed ID: 20153798
[TBL] [Abstract][Full Text] [Related]
11. National Athletic Trainers' Association position statement: anabolic-androgenic steroids.
Kersey RD; Elliot DL; Goldberg L; Kanayama G; Leone JE; Pavlovich M; Pope HG;
J Athl Train; 2012; 47(5):567-88. PubMed ID: 23068595
[TBL] [Abstract][Full Text] [Related]
12. Health service engagement, side effects and concerns among men with anabolic-androgenic steroid use: a cross-sectional Norwegian study.
Henriksen HCB; Havnes IA; Jørstad ML; Bjørnebekk A
Subst Abuse Treat Prev Policy; 2023 Apr; 18(1):19. PubMed ID: 37013635
[TBL] [Abstract][Full Text] [Related]
13. Anabolic-androgenic steroids are linked to depression and anxiety in male bodybuilders: the hidden psychogenic side of anabolic androgenic steroids.
Karagun B; Altug S
Ann Med; 2024 Dec; 56(1):2337717. PubMed ID: 38590148
[TBL] [Abstract][Full Text] [Related]
14. Anabolic-androgenic steroids (AAS) users on AAS use: Negative effects, 'code of silence', and implications for forensic and medical professionals.
Richardson A; Antonopoulos GA
J Forensic Leg Med; 2019 Nov; 68():101871. PubMed ID: 31557629
[TBL] [Abstract][Full Text] [Related]
15. Sudden Cardiac Death in Anabolic-Androgenic Steroid Users: A Literature Review.
Torrisi M; Pennisi G; Russo I; Amico F; Esposito M; Liberto A; Cocimano G; Salerno M; Li Rosi G; Di Nunno N; Montana A
Medicina (Kaunas); 2020 Nov; 56(11):. PubMed ID: 33158202
[No Abstract] [Full Text] [Related]
16. Anabolic-androgenic steroids: How do they work and what are the risks?
Bond P; Smit DL; de Ronde W
Front Endocrinol (Lausanne); 2022; 13():1059473. PubMed ID: 36644692
[TBL] [Abstract][Full Text] [Related]
17. Physical appearance concerns are uniquely associated with the severity of steroid dependence and depression in anabolic-androgenic steroid users.
Griffiths S; Jacka B; Degenhardt L; Murray SB; Larance B
Drug Alcohol Rev; 2018 Jul; 37(5):664-670. PubMed ID: 29484740
[TBL] [Abstract][Full Text] [Related]
18. Doping and sports endocrinology: anabolic-androgenic steroids.
García-Arnés JA; García-Casares N
Rev Clin Esp (Barc); 2022 Dec; 222(10):612-620. PubMed ID: 36400345
[TBL] [Abstract][Full Text] [Related]
19. Psychiatric and medical effects of anabolic-androgenic steroid use in women.
Gruber AJ; Pope HG
Psychother Psychosom; 2000; 69(1):19-26. PubMed ID: 10601831
[TBL] [Abstract][Full Text] [Related]
20. Severe biventricular cardiomyopathy in both current and former long-term users of anabolic-androgenic steroids.
Abdullah R; Bjørnebekk A; Hauger LE; Hullstein IR; Edvardsen T; Haugaa KH; Almaas VM
Eur J Prev Cardiol; 2024 Mar; 31(5):599-608. PubMed ID: 37992194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
